Cubist Systematic Strategies’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-6,152
| Closed | -$22.9K | – | 2461 |
|
2024
Q3 | $22.9K | Sell |
6,152
-19,660
| -76% | -$73.3K | ﹤0.01% | 1314 |
|
2024
Q2 | $145K | Buy |
+25,812
| New | +$145K | ﹤0.01% | 1130 |
|
2024
Q1 | – | Sell |
-15,228
| Closed | -$79.6K | – | 2919 |
|
2023
Q4 | $79.6K | Sell |
15,228
-43,303
| -74% | -$226K | ﹤0.01% | 1814 |
|
2023
Q3 | $923K | Sell |
58,531
-15,977
| -21% | -$252K | 0.01% | 1071 |
|
2023
Q2 | $1.45M | Buy |
74,508
+36,440
| +96% | +$708K | 0.01% | 1029 |
|
2023
Q1 | $1.08M | Buy |
38,068
+31,881
| +515% | +$904K | 0.01% | 1435 |
|
2022
Q4 | $181K | Buy |
+6,187
| New | +$181K | ﹤0.01% | 2687 |
|
2022
Q3 | – | Sell |
-9,658
| Closed | -$429K | – | 3982 |
|
2022
Q2 | $429K | Sell |
9,658
-3,021
| -24% | -$134K | ﹤0.01% | 2715 |
|
2022
Q1 | $627K | Buy |
12,679
+4,356
| +52% | +$215K | 0.01% | 2370 |
|
2021
Q4 | $424K | Sell |
8,323
-4,357
| -34% | -$222K | ﹤0.01% | 2568 |
|
2021
Q3 | $707K | Buy |
12,680
+4,346
| +52% | +$242K | 0.01% | 1788 |
|
2021
Q2 | $357K | Sell |
8,334
-7,667
| -48% | -$328K | ﹤0.01% | 2226 |
|
2021
Q1 | $668K | Buy |
16,001
+7,401
| +86% | +$309K | 0.01% | 1793 |
|
2020
Q4 | $401K | Buy |
8,600
+2,734
| +47% | +$127K | 0.01% | 1896 |
|
2020
Q3 | $249K | Buy |
+5,866
| New | +$249K | ﹤0.01% | 2047 |
|
2020
Q2 | – | Sell |
-5,463
| Closed | -$251K | – | 2558 |
|
2020
Q1 | $251K | Buy |
+5,463
| New | +$251K | 0.01% | 1607 |
|
2019
Q4 | – | Sell |
-5,862
| Closed | -$332K | – | 2581 |
|
2019
Q3 | $332K | Sell |
5,862
-2,815
| -32% | -$159K | 0.01% | 1507 |
|
2019
Q2 | $483K | Buy |
8,677
+214
| +3% | +$11.9K | 0.01% | 1494 |
|
2019
Q1 | $427K | Sell |
8,463
-15,043
| -64% | -$759K | 0.01% | 1288 |
|
2018
Q4 | $947K | Buy |
+23,506
| New | +$947K | 0.04% | 585 |
|
2017
Q4 | – | Sell |
-6,554
| Closed | -$391K | – | 2136 |
|
2017
Q3 | $391K | Buy |
6,554
+2,852
| +77% | +$170K | 0.02% | 980 |
|
2017
Q2 | $292K | Buy |
+3,702
| New | +$292K | 0.02% | 1054 |
|
2016
Q2 | – | Sell |
-1,378
| Closed | -$56K | – | 1919 |
|
2016
Q1 | $56K | Buy |
+1,378
| New | +$56K | ﹤0.01% | 1466 |
|
2015
Q4 | – | Sell |
-3,962
| Closed | -$293K | – | 1981 |
|
2015
Q3 | $293K | Buy |
3,962
+344
| +10% | +$25.4K | 0.01% | 1243 |
|
2015
Q2 | $293K | Sell |
3,618
-22,354
| -86% | -$1.81M | 0.01% | 1234 |
|
2015
Q1 | $1.09M | Buy |
+25,972
| New | +$1.09M | 0.05% | 526 |
|